• ქართული
  • English
  • Pfizer to buy cancer drug developer Array for $10.64 billion

    Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline.

    Market Quotes by TradingView